Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

ICU Medical, Inc. (ICUI) had Revenue of $2.38B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.38B
Net Income	$-117.69M
Cost of Goods Sold	$1.56B
Gross Profit	$824.78M
Operating Expenses	$2.34B
Operating Income	$42.96M
Non-Operating Income/Expense	$-108.98M
Pre-Tax Income	$-66.01M
Normalized Pre-Tax Income	$-66.01M
Income after Taxes	$-117.69M
Income from Continuous Operations	$-117.69M
Consolidated Net Income/Loss	$-117.69M
Normalized Income after Taxes	$-117.69M
EBIT	$42.96M
EBITDA	$269.28M
Weighted-Average Shares Outstanding (Basic)	24.39M
Weighted-Average Shares Outstanding (Diluted)	24.39M
Earnings per Share (EPS) (Basic)	$-4.83
Earnings per Share (EPS) (Diluted)	$-4.83
Balance Sheet Financials
Current Assets	$1.44B
Property, Plant, and Equipment	$442.75M
Long-Term Assets	$2.76B
Total Assets	$4.20B
Current Liabilities	$556.18M
Long-Term Debt	$1.53B
Long-Term Liabilities	$1.68B
Total Liabilities	$2.24B
Common Equity	$1.97B
Tangible Shareholders Equity	$-208.33M
Shareholders Equity	$1.97B
Common Shares Outstanding	24.52M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$204.03M
Cash Flow from Investing Activities	$-88.96M
Cash Flow from Financial Activities	$-55.80M
Beginning Cash	$254.22M
End Cash	$308.57M
Increase/Decrease in Cash	$54.34M
Stock-Based Compensation	$46.88M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.81
Gross Margin	34.62%
Operating Margin	1.80%
EBIT Margin	1.80%
EBITDA Margin	11.30%
Pre-Tax Profit Margin	-2.77%
Profit Margin	-4.94%
Free Cash Flow	$125.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.57
Inventory Turnover	2.66
Receiveable Turnover	13.03
Days Sales in Receivables	28.01
Return on Equity	-5.99%
Return on Tangible Equity	56.49%
Return on Assets	-2.80%
Return on Investments	-3.37%
Book Value Per Share	$80.16
Free Cash Flow per Share	$5.14
Operating Cash Flow per Share	$8.37

Data from Zacks Investment Research, Inc.